1.1 Regional Market Share
1.2 Key Business Trends
1.3 Regional Trends
1.4 Segmentation Snapshot
2.1 Research Objective
2.2 Research Approach
2.3 Data Sourcing and Methodology
2.4 Primary Research
2.5 Secondary Research
2.5.1 Paid Sources
2.5.2 Public Sources
2.6 Market Size Estimation and Data Triangulation
3.1 Market Definition
3.2 Key Segmentations
3.3 Key Developments
3.4 Allied Industry Data
4.1 Industry Segmentation
4.2 Innovation Sustainability (CRISPR, Humanized, PDX)
4.3 Life Sciences & Preclinical Ecosystem Channel Analysis
4.4 Macroeconomic Indicators
4.5 Recent Developments
4.6 Market Dynamics
4.6.1 Introduction
4.6.2 Growth Drivers
4.6.3 Market Opportunities
4.6.4 Market Restraints
4.6.5 Market Trends
4.7 Risk Analysis
4.8 Market Analysis
4.8.1 Porter’s Five Forces
4.8.2 PEST Analysis
4.8.2.1 Political
4.8.2.2 Economic
4.8.2.3 Social
4.8.2.4 Technological
5.1 Market Overview
5.2 Historical Analysis 2019–2023
5.2.1 Market Size, Y-o-Y Growth and Market Forecast
6.1 Overview
6.2 Key Findings
6.3 Market Segmentation
6.3.1.1 Mice
6.3.1.2 Rats
6.3.1.3 Zebrafish
6.3.1.4 Rabbits & Guinea Pigs
6.3.1.5 Dogs, Pigs & Non-Human Primates
6.3.2.1 Pre-Clinical Drug Development
6.3.2.2 Toxicology Studies
6.3.2.3 Oncology
6.3.2.4 Neurology
6.3.2.5 Immunology
6.3.2.6 Infectious Disease
6.3.2.7 Genetic Research
6.3.2.8 Others
6.3.3.1 Pharmaceutical & Biotechnology Companies
6.3.3.2 Contract Research Organizations (CROs)
6.3.3.3 Academic & Research Institutions
6.3.3.4 Government Laboratories
6.3.3.5 Others (if required)
6.3.4.1 Transgenic / Knockout Models
6.3.4.2 Humanized Models
6.3.4.3 PDX (Patient-Derived Xenografts)
6.3.4.4 CRISPR-Edited Disease Models
6.3.4.5 Immunodeficient Models
7.1 Overview
7.2 Key Findings
7.3 Market Segmentation
7.4 Country Analysis
7.4.1 United States
7.4.2 Canada
8.1 Overview
8.2 Key Findings
8.3 Market Segmentation
8.4 Country Analysis
8.4.1 Germany
8.4.2 United Kingdom
8.4.3 France
8.4.4 Italy
8.4.5 Spain
8.4.6 Rest of Europe
9.1 Overview
9.2 Key Findings
9.3 Market Segmentation
9.4 Country Analysis
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 South Korea
9.4.5 Rest of APAC
10.1 Overview
10.2 Key Findings
10.3 Market Segmentation
10.4 Country Analysis
10.4.1 Saudi Arabia
10.4.2 UAE
10.4.3 South Africa
10.4.4 Rest of MEA
11.1 Overview
11.2 Key Findings
11.3 Market Segmentation
11.4 Country Analysis
11.4.1 Brazil
11.4.2 Mexico
11.4.3 Rest of Latin America
12.1 Company Market Share, 2024
12.2 Key Stakeholders
12.3 Competitive Benchmarking
13.1 Charles River Laboratories
13.2 Taconic Biosciences
13.3 The Jackson Laboratory (JAX)
13.4 Envigo (Inotiv)
13.5 Crown Bioscience
13.6 GenOway
13.7 Janvier Labs
13.8 Biomere
13.9 Horizon Discovery
13.10 Zoetis R&D
For each company:
Select License Type
Our Clients
We have been working with some Fortune 500+ clients
.png){kind=icon}
